- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02580084
Clinical Study of the Aorta-femoral Bypass and Hybrid Intervention and the Iliac Arteries With Stenting and Plasty of the Common Femoral Artery Effectiveness in Patients With the Iliac Segment and Femoral Artery Occlusive Disease (TASC C, D)
Prospective Randomized Clinical Study of the Aorta-femoral Bypass and Hybrid Intervention and the Iliac Arteries With Stenting and Plasty of the Common Femoral Artery Effectiveness in Patients With the Iliac Segment and Femoral Artery Occlusive Disease (TASC C, D)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Currently, according to the TASC II consensus document (2007) and the Russian guidelines for limb ischemia treatment (2010), aorta-iliac C and D type segment lesions the open surgery is suggested.
According to different studies, 76% occlusive aorta-iliac article course patients indicate femoral-popliteal segment lesions. Due to the lack of inflow and outflow ways of correction needed for adequate limb revascularization surgery treatment of multistorey atherosclerotic lesions patients is still one of the most complex problems of vascular surgery. Perioperational mortality of critical limb ischemia patients reaches 5-10% in retrograde aorta-iliac segment reconstruction.
Due to its high efficiency hybrid operative invasion is one of the most perspective directions in reconstructive vascular surgery development (92-98% of the cases with the small number of post-operative complications).
Furthermore, hybrid surgery is possible with the critical iliac segment and femoral artery lesions, since stenting in the field of physiological bends (femoral artery) may lead to its breaking and artery thrombosis. Arterial segments blood flow reconstruction is possible with hybrid innervations meaning iliac segment stenting and common femoral artery patch.
All reports of iliac arteries stenosis percutaneous angioplasty indicate that the primary technical and clinical success rate exceeds 90%. The technical success of iliac arteries long occlusions recanalization reaches 80-85%. Improvement of endovascular equipment designed for the total occlusions treatment increases technical success of recanalization. The TASC II materials summarize the several large studies results which present the data on the operated segment artery patency at the level of 70-81% within 5-8 years of follow up. A large number of authors note the actuality of aortic-iliac type C and D segment lesions endovascular treatment recommendations revision according to the TASC II, together with hybrid technics implementation in this category of patients.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Novosibirsk, Russian Federation, 630055
- NRICP
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients with occlusive lesions of C and D type iliac segment and steno-occlusive lesions of the common femoral artery, and with chronic lower limb ischemia (II-IV degree by Fontaine, 2-5 degree by Rutherford), age: 47-75 years old.
- Patients who consented to participate in this study
Exclusion Criteria:
- Chronic heart failure of III-IV functional class by New York Heart Association classification.
- Patients who have suffered a stroke or myocardial infarction less than 3 months
- Significant Steno-occlusive lesion of the contralateral side
- Decompensated chronic "pulmonary" heart
- Aortoarteritis
- Severe hepatic or renal failure (bilirubin> 35 mmol / l, glomerular filtration rate <60 mL / min);
- Polyvalent drug allergy
- Cancer in the terminal stage with a life expectancy less than 6 months
- Expressed aortic calcification tolerant to angioplasty
- Patient refusal to participate or continue to participate in the study
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Single Group Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: aorta femoral bypass
It is sufficient to identify only the anterior-lateral aorta surface.
After heparinization the aorta is clamped above and below the anastomosis.
The aorta is dissected along the anterior wall, calcium portions or mural thrombus are removed.
Prosthesis is cut obliquely and anastomosis suturing starts with distal angle.
Occluded at the prosthetic base jaws, aortic compressor is removed, restoring blood flow in the lower limb.
Next stage is tunnel creating for jaws prosthesis conduction on hip.
Ureters must remain over the prosthesis, jaw should be above the iliac arteries.
After jaws prosthesis conduction on hip distal anastomosis is formed with twisting controlling.
Before anastomosis completion the testing jaws and all arteries bloodletting is performed.
|
It is sufficient to identify only the anterior-lateral aorta surface.
After heparinization the aorta is clamped above and below the anastomosis.
The aorta is dissected along the anterior wall, calcium portions or mural thrombus are removed.
Prosthesis is cut obliquely and anastomosis suturing starts with distal angle.
Occluded at the prosthetic base jaws, aortic compressor is removed, restoring blood flow in the lower limb.
Next stage is tunnel creating for jaws prosthesis conduction on hip.
Ureters must remain over the prosthesis, jaw should be above the iliac arteries.
After jaws prosthesis conduction on hip distal anastomosis is formed with twisting controlling.
Before anastomosis completion the testing jaws and all arteries bloodletting is performed.
|
|
Experimental: hybrid intervention
Iliac Arteries With Stenting and Plasty of the Common Femoral Artery
|
The puncture of the femoral artery general is executed and the introducer 7Fr is set. Further, the hydrophilic conductor executes a recanalization of the Vasa of iliac artery occlusion. if you cannot pass the occlusion retrograde is additional access to antegrade recanalization. Then using hydrophilic conductors, an iliac artery antegrade or retrograde recanalization of the Vasa is made. Femoral artery arteriotomy. Further execute a direct endarterectomy femoral artery and from the mouth of a hip artery. arteriotomy of the femoral artery is closed with a vascular patch use (synthetic or biological). Balloon angioplasty and stenting, iliac artery is done, the controlling angiography Closing maims. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Safety assessment in the 30-day period: clinically significant bleeding, hematoma, infection of the prosthesis, infection of the postoperative wound, lymphorrhea, renal failure, myocardial infarction, stroke, mortality, thrombosis of the operated segment
Time Frame: 30 days
|
Identification of serious adverse events requiring correction of therapy or surgery.
Will be used physiological parameter and questionnaire.
Classification of bleeding will be used GUSTO (Severe or moderate)
|
30 days
|
|
Evaluation of efficiency: primary patency, secondary patency success of procedures, length of hospital stay
Time Frame: 30 days
|
If a damage confirmed by duplex is detected, repeat intervention is performed on the side of the examined segment
|
30 days
|
|
Evaluation of efficiency: success of procedures
Time Frame: 30 days
|
Technical feasibility of the procedure
|
30 days
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
mortality
Time Frame: during the whole period of observation. Observation is 36 month after surgery
|
during the whole period of observation. Observation is 36 month after surgery
|
|
stroke
Time Frame: during the whole period of observation. Observation is 36 month after surgery
|
during the whole period of observation. Observation is 36 month after surgery
|
|
myocardial infarction
Time Frame: during the whole period of observation. Observation is 36 month after surgery
|
during the whole period of observation. Observation is 36 month after surgery
|
|
limb salvage
Time Frame: in the early postoperative period. Surveillance is 36 month after surgery
|
in the early postoperative period. Surveillance is 36 month after surgery
|
|
infection of the prosthesis
Time Frame: during the whole period of observation. Observation is 36 month after surgery
|
during the whole period of observation. Observation is 36 month after surgery
|
Collaborators and Investigators
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- NRICP111
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Atherosclerosis of the Peripheral Arteries
-
Meshalkin Research Institute of Pathology of CirculationAbbottUnknownAtherosclerosis of the Peripheral ArteriesRussian Federation
-
Meshalkin Research Institute of Pathology of CirculationTerminatedСhronic Ischemia of the Lower Extremities | Atherosclerosis of the Tibial Arteries | Lesion no More Than Two Tibial Arteries | Steno-occlusive Lesion of the Tibial ArteriesRussian Federation
-
ODI Medical ASRecruitingPercutaneous Transluminal Angioplasty | Atherosclerosis of Arteries of the Extremities, UnspecifiedNorway
-
Boston Scientific CorporationCompletedAtherosclerosis of Native Arteries of the ExtremitiesNew Zealand, United States, Belgium, Canada, Japan, Germany, Austria
-
Boston Scientific CorporationCompletedAtherosclerosis of Native Arteries of the ExtremitiesNew Zealand, Germany, Belgium, Australia, Austria
-
Boston Scientific CorporationCompletedAtherosclerosis of Native Arteries of the Extremities, UnspecifiedBelgium, United States, United Kingdom, Japan, Austria, Canada, Germany
-
Jie QiuNational Natural Science Foundation of ChinaCompletedAtherosclerosis of Arteries of the Extremities, Unspecified
-
Lumen BiomedicalCompleted
-
BayerCompletedPeripheral Arterial Disease | Atherosclerosis | Stenotic Femoro-popliteal Arteries | Occluded Femoro-popliteal ArteriesGermany
-
Centre Hospitalier Universitaire de NīmesCompletedUnilateral vs Bilateral Embolization of the Prostate ArteriesFrance
Clinical Trials on Aorta femoral Bypass
-
University of AlbertaCompletedCoronary Artery DiseaseCanada
-
Texas Vascular AssociatesW.L.Gore & AssociatesCompletedAtherosclerosis | Claudication | Lower Extremity Ischemia | Rest PainUnited States
-
Guangzhou General Hospital of Guangzhou Military...RecruitingAtrial Fibrillation | Valvular Heart DiseaseChina
-
University of PecsCompletedIschemia Reperfusion Injury
-
St. Antonius HospitalUMC Utrecht; Albert Schweitzer Hospital; Amphia HospitalUnknownAtherosclerosis | Peripheral Arterial Occlusive DiseaseNetherlands
-
Clinical Centre of SerbiaUniversity of Trieste; University of Belgrade; Centro Hospitalar De São João,... and other collaboratorsRecruitingPeripheral Arterial Disease | Peripheral Vascular Disease | Aortoiliac Occlusive Disease | Leriche SyndromeSerbia
-
Texas Vascular AssociatesW.L.Gore & AssociatesCompletedAtherosclerosis | Claudication | Lower Extremity Ischemia | Rest PainUnited States
-
China National Center for Cardiovascular DiseasesRecruitingCoronary Artery Bypass Graft (CABG)China
-
Aiatella OyRecruitingAortic Aneurysm | Aortic Aneurysm, Thoracoabdominal | Aortic Aneurysm Abdominal | Aortic Aneurysm and DissectionUnited States, Brazil
-
University Hospital, CaenNot yet recruiting